Report of the Canadian hypertension society consensus conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy

CMAJ. Canadian Medical Association Journal

Volumn 157, Issue 7, 1997, Pages 907-919

  Moutquin, Jean Marie ^a   Garner, Peter R ^b   Burrows, Robert F ^c,d   Rey, Evelyne ^e   Helewa, Michael E ^f   Lange, Ian R ^g   Rabkin, Simon W ^h  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; FISH OIL;

AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DIET THERAPY; FEMALE; FETUS OUTCOME; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INTRAUTERINE GROWTH RETARDATION; LIFESTYLE; MATERNAL HYPERTENSION; NUTRIENT; PLASMA VOLUME; PRACTICE GUIDELINE; REST; SYSTOLIC BLOOD PRESSURE;

EID: 0030771078     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. National High Blood Pressure Education Program Working Group Report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990;163:1689-712.
2. World Health Organization Study Group. The hypertensive disorders of pregnancy. No 758 of Technical Reports series. Geneva: The Organization; 1987.
3. Friedman EA, Neff RK. Pregnancy hypertension: a systematic evaluation of clinical diagnostic criteria. Littleton (MA): P.S.G. Publishing; 1977.
4. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. Can Med Assoc J 1997;157:715-25.
5. Chalmers I, Enkin MW, Keirse MJNC, editors. Effective care in obstetrics. 2 vol. New York: Oxford University Press; 1989.
6. Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
7. Carruthers SG, Larochelle P, Haynes RH, Petrasovitz A, Schiffrin EL. Report of the Canadian Hypertension Society Consensus Conference: I. Introduction. Can Med Assoc J 1993;149:289-92.
8. Australasian Society for the Study of Hypertension in Pregnancy. Management of hypertension in pregnancy. Consensus Statement. Melbourne: The Society; 1993. p. 1-48.
9. Curet LB, Olson RW. Evaluation of a program of bed rest in the treatment of chronic hypertension in pregnancy. Obstet Gynecol 1979;53:336-40.
10. Mathews DD. A randomized controlled trial of bed rest and sedation or normal activity and non sedation in the management of non albuminurie hypertension in late pregnancy. Br J Obstet Gynaecol 1977;84:108-14.
11. Helewa M, Heaman M, Robinson MA, Thompson L. Community-based home-care program for the management of pre-eclampsia: an alternative. Can Med Assoc J 1993;149:829-34.
12. Rosenberg K, Twaddle S. Screening and surveillance of pregnancy hypertension. An economic approach to the use of day-care. Baillieres Clin Obstet Gynaecol 1990;4:89-107.
13. Tuffnell DJ, Lilford RJ, Buchan PC, Prendiville VM, Tuffnell AJ, Holgate MP, et al. Randomized controlled trial of day-care for hypertension in pregnancy. Lancet 1992;339:224-7.
14. Barton JR, Stanziano G, Sibai BM. Monitored outpatients management of mild gestational hypertension remote from term. Am J Obstet Gynecol 1994;170:765-9.
15. Moutquin JM, Rainville C, Amyot G, Raynault P, Bilodeau R. Are blood pressure increments predictive of preeclampsia? A prospective cohort study. Clin Exp Hypertens B 1990;9:225-35.
16. Zuspan FP, Rayburn WF. Blood pressure self-monitoring during pregnancy: practical considerations. Am J Obstet Gynecol 1991;164:2-6.
17. Rayburn WF, Zuspan FP, Piebl EJ. Self-monitoring of blood pressure during pregnancy. Am J Obstet Gynecol 1984;148:159-62.
18. Haligan A, O'Brien E, O'Malley K, Mee F, Atkins N, Conroy R, et al. Twenty-four hour ambulatory blood pressure measurement in a primigravid population. J Hypertens 1993;11:869-73.
19. Moutquin JM, Desmarais L, Turcot L, Forest JC. Reference standards of ambulatory blood pressure monitoring in normotensive and hypertensive pregnancy [abstract]. Int J Gynecol Obstet 1994;46(suppl.2):139.
20. Moutquin J.M. Prédiction de la prééclampsie par la tension artérielle ambulatoire. J Gynecol Obstet Biol Reprod (Paris) 1992;21:313-5.
21. Chari RS, Frangieh AY, Sibai BM. Chronic hypertension in pregnancy. Compr Ther 1995;21:227-34.
22. Mabie WC, Pernoll ML, Biswas NK. Chronic hypertension in pregnancy. Obstet Gynecol 1986;67:197-205.
23. Sibai BM, Usta IM. Chronic hypertension in pregnancy. In: Sciarra JJ, editor. Obstetrics and gynaecology. Vol 3, ch 5. Philadelphia: JB Lippincott; 1995. p. 1-19
24. Josten LE, Savik K, Mullett SE, Campbell R, Vincent P. Bedrest compliance for women with pregnancy problems. Birth 1995;22:1-12.
25. Crowther CA, Bouwmeester AM, Ashurst HM. Does admission to hospital for bed rest prevent progression or improve fetal outcome in pregnancy complicated by non-proteinuric hypertension? Br J Obstet Gynaecol 1992;99;13-8.
26. Duley L, Hospitalization for non-proteinuric pregnancy hypertension. Review no 03371, May 21, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
27. Crowther CA. Strict bed rest vs ambulation in the management of patients with proteinuric hypertension in pregnancy. Reported in: Duley L. Strict bed rest for proteinuric hypertension in pregnancy. Review no 03373, May 21, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
28. Kramer MS. Regular aerobic exercise during pregnancy. Review no 07208, Aug 5, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
29. Matthews DD, Agarwal V, Shuttleworth TP. A randomised controlled trial of complete bed rest vs ambulation in the management of proteinuric hypertension during pregnancy. Br J Obstet Gynaecol 1982;89:128-31.
30. Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in preeclampsia and pregnancy. Clin Sci 1994;86:731-9.
31. Tinkanen H, Rorarius M, Metsa-Ketela T. Catechulamine concentrations in venous plasma and cerebrospinal fluid in normal and complicated pregnancy. Gynecol Obstet Invest 1993;35:7-11.
32. Nisell H, Larsson G, Wager L. The relations between life stress and hypertensive complications during pregnancy. Acta Obstet Gynecol Scand 1989; 68:423-7.
33. Hankin ME, Symonds EM. Body weight, diet and preeclamptic toxaemia of pregnancy. Aust N Z J Obstet Gynaecol 1962;4:156-60.
34. Kramer MS. Isocaloric balanced protein supplementation in pregnancy. Review no 07140, Aug 5, 1993. In: Enkin MW, Keirse MJNC;, Renfrew MJ, N Neilson JP, Editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
35. Kramer MS. Balanced protein/energy supplementation in pregnancy. Review no 07141, Sept 17, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK); Update Software; 1994. Issue 1.
36. Kramer MS. Energy, protein restriction in pregnant women with high weight-for-height or weight gain. Review no 07139, Aug 5, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
37. Duley L. Low vs high salt intake in pregnancy. Review no 05939, Apr 20, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
38. Spatling L, Spatling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol 1988;95:120-5.
39. Sibai BM, Vilar MA, Bray E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol 1989; 161:115-9.
40. Rudnicki M, Frolich A, Rasmussen WF, McNair P. The effects of magnesium on maternal blood pressure in pregnancy-induced hypertension. Acta Obstet Gynaecol 1991;70:445-50.
41. Duley L. Routine calcium supplementation in pregnancy. Review no 05938, June 23, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
42. Sanchez-Ramos L, Adair CD, Kaunitz AM, Briones DK, Del Valle GO, Delke J. Calcium supplementation in mild preeclampsia remote from term: a randomized double-blind clinical trial. Obstet Gynecol 1995;85:915-8.
43. Mohamed K. Routine zinc supplementation in pregnancy. Review no 06944, Apr 28, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
44. Mahomed K. Routine iron supplementation in pregnancy. Review no 03157, Apr 28, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
45. Mahomed K. Routine folate supplementation in pregnancy. Review no 03158, Apr 28, 1993. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
46. Mardones-Santander F, Rosso P, Stekel A, Ahunador E, Llaguna S, Pizarro F, et al. Effect of milk-based food supplement on maternal nutritional status and fetal growth in underweight Chilean women. Am J Clin Nutr 1988;47:463-9.
47. Ross RA, Perlzweig WA, Taylor HM, McBryde A, Yates A, Kondritzer AA, et al. A study of certain dietary factors of possible etiologic significance in toxemias of pregnancy. Am J Obstet Gynecol 1938;35:426-4.
48. Girija A, Geervani P, Rao GN. Inference of dietary supplementation during pregnancy on lactation performances. J Trop Pediatr 1984;30:79-83.
49. Mora JO, Clement J, Christiansen N, Suescun J, Wagner M, Herrera MG. Nutritional supplementation and the outcome of pregnancy. III. Perinatal and neonatal mortality. Nutr Rep Int 1978;18:167-75.
50. Campbell DM, MacGillivray I. The effect of low calories diet or thiazide diuretic on the incidence of preeclampsia and birthweight. Br J Obstet Gynaecol 1975;82:572-7.
51. Blumenthal I. Diet and diuretics in pregnancy and subsequent growth of offspring. BMJ 1976;2:733.
52. Jacobson HN, Burke BS, Smith CA, et al. Effect of weight reduction in obese pregnant women on pregnancy, labour and delivery. Am J Obstet Gynecol 1962;83:1609-16.
53. Hytten FE. Weight gain in pregnancy - 30 years of research. S Afr Med J 1981;60:15-9.
54. Campbell DM. Dietary restriction in obesity and its effect on neonatal outcome. In: Campbell DM, Gillmer MDG, editors. Nutrition in pregnancy. Proceedings of 10th Study Group of the Royal College of Obstetricians and G Gynaecologist, London: The College; 1983. p 243-50.
55. Gallery ED, Hunyor SN, Gyory AZ. Plasma volume contraction - a significant factor in both pregnancy associated hypertension and chronic hypertension in pregnancy. Q J Med 1979;48:593-602.
56. Nabeshima K. Effect of salt restriction on preeclampsia. Nippon Jinzo Gakkai Shi 1994;36:227-32.
57. Steegers EAP, Van Lakwijk HPJM, Jongsma HW. Fast JH, DeBoo T, Eskes TKAB, et al. Pathophysiological implications of chronic dietary sodium restriction during pregnancy, a longitudinal prospective randomized study Br J Obstet Gynaecol 1991;98:980-7.
58. Eskenazi B, Fenster L, Sidney S. A multivariate analysis of risk factors for preeclampsia. JAMA 1991;266:237-41.
59. Passaro KT, Little RE, Savitz, DA, Noss J, and the ALSPAC Study Team. The effect of maternal drinking before conception and in early pregnancy on infant birthweight. Epidemiol 1996;7:377-83.
60. Florey CV, Taylor D, Bolumar F, Kaminski M, Olsen J, editors. EURO-MAC. A european concerted action: maternal alcohol consumption and its relation to the outcome of pregnancy and child development at 18 months. Int J Epidemiol 1992;21(suppl 1).
61. Alcohol consumption in pregnancy [RCOG Guidelines report no 9]. London: Royal College of Obstetricians and Gynaecologists; November 1996.
62. Villar J, Belizan JM, Fischer PJ. Epidemiological observations on the relationship between calcium intake and eclampsia. Int J Gynecol Obstet 1983;21: 271-8.
63. Sowers JR, Zemel MB, Bromsteen RA, Zemell PC, Walsh MF, Standley MS, et al. Erythrocyte cation metabolism in preeclampsia. Am J Obstet Gynecol 1989;161:441-5.
64. Haller H, Oeney T, Hauck V, Distler A, Philip T. Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. Am J Hypertens 1989;2:238-48.
65. Taufield PA, Ales KL, Resnick LM, Druzin ML, Gertner JM, Laragh JH. Hypo-calciuria in preeclampsia. N Engl J Med 1987;316:715-8.
66. Belizan JM, Villar J, Repke J. The relationship between calcium intake and pregnancy induced hypertension: up-to-date evidence. Am J Obstet Gynecol 1988;158:898-902.
67. Belizan JM, Villar J, Gonzalez L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med 1991;325:1399-405.
68. Lopez-Jaramillo P, Narvaez M, Weigel RM, Yepez R. Calcium supplementation reduces the risk of pregnancy-induced hypertension in an Andes population. Br J Obstet Gynaecol 1989;96:648-55.
69. Lopez-Jaramillo P, Narvaez M, Felix C, Lopez A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet 1990;335:293.
70. Montanaro D, Boscutti G, Mioni G, Driul P, Tosolini G. Calcium supplementation decreases the incidence of pregnancy-induced hypertension (PIH) and preeclampsia (PE). Proceedings of the 7th World Congress of Hypertension in Pregnancy. Perugia, Italy; 1990.
71. Villar J, Repke J. Calcium supplementation during pregnancy may reduce preterm delivery in high-risk populations. Am J Obstet Gynecol 1990;163:1124-31.
72. Villar J, Repke J, Belizan JM, Pareja G. Calcium supplementation reduces blood pressure during pregnancy: results of a randomized controlled clinical trial. Obstet Gynecol 1987;70:317-22.
73. Bucher HC, Guyatt GH, Cook RJ, Hatala R, Cook DJ, Lang JD, et al. Effect of calcium supplementation and pregnancy-induced hypertension and preeclampsia. A meta-analysis of randomized controlled trials. JAMA 1996; 275:1113-9.
74. Ito M, Koyama H, Ohshige A. Prevention of preeclampsia with calcium supplementation and vitamin D3 in an antenatal protocol. Int J Gynaecol Obstet 1994;47:115-20.
75. Sanchez-Ramos L, Briones DK, Kaunitz AM, Del Valle GO, Gaudin FL, et al. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II sensitive patients. Obstet Gynecol 1994;84:349-53.
76. Hunt IF, Murphy NJ, Cleaver AE, Faraji B, Swendaid ME, Coulson AH, et al. Zinc supplementation during pregnancy: effects on selected blood constituents and on progress and outcome of pregnancy in low income women of mexican descent. Am J Clin Nutr 1984;40:508-21.
77. Mahomed K, James DK, Golding J, McCabe R. Zinc supplementation during pregnancy: a double-blind randomized controlled trial. BMJ 1989;298:826-30.
78. Dawson EB, McGanity WJ. Protection of maternal iron stores in pregnancy. J Reprod Med 1987;328:478-87.
79. Paintin DB, Thomson AM, Hytten FE. Iron and haemoglobin level in pregnancy. J Obstet Gynaecol Br Commonw 1966;73:181-90.
80. Taylor DJ, Mallen C, McDougall N, Lind T. Effect of iron supplementation on serum ferritin levels during and after pregnancy. Br J Obstet Gynaecol 1982; 89:1011-7.
81. Fleming AF, Hendricks JP, Allan NC. The prevention of megaloblastic anaemia in pregnancy in Nigeria. J Obstet Gynaecol Br Commonw 1968;75:425-32.
82. Fletcher J, Gurr A, Fellingham FR, Prankerd TAJ, Brant HA, Menzies DN. The value of folic acid supplements in pregnancy. J Obstet Gynaecol Br Commonw 1971;78:781-5.
83. Iyengar L. Folic acid requirements of Indian pregnant women. Am J Obstet Gynecol 1971;111:13-6.
84. Duley L. Plasma volume expansion in pregnancy-induced hypertension. Review no 05734, June 2, 1992. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
85. Duley L. Prophylactic fish oil in pregnancy. Review no 05941, Apr 21, 1994. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Cochrane database of systematic reviews. Oxford (UK): Update Software; 1994. Issue 1.
86. CLASP Collaborative Group. A randomized trial of low-dose aspirin for the prevention and treatment of preeclampsia among 9364 pregnant women. Lancet 1994;343:619-23.
87. Belfort M, Uys P, Domisse J, Davey DA. Haemodynamic changes in gestational proteinuric hypertension: the effects of rapid volume expansion and vasodilator therapy. Br J Obstet Gynaecol 1989;96:634-41.
88. Sehgal NN, Hitt JR. Plasma volume expansion in the treatment of preeclampsia. Am J Obstet Gynecol 1980;138:165-8.
89. Moodley J, Norman RJ. Attempts at dietary alteration of prostaglandin pathways in the management of preeclampsia. Prostaglandins Leukot Essent Fatty Acids 1989;37:145-7.
90. People's League of Health Nutrition and Expectant and Nursing Mothers. Interim report. Lancet 1942;2:10-2.
91. Olsen SF, Sorensen JD, Secher NJ, Hidegaard M, Henrikscn TB, Hansen HS, et al. Randomized-controlled trial of effect of fish oil supplementation on pregnancy duration. Lancet 1992;339:1003-7.
92. Onwude JL, Lilford RJ, Hiartardottir H, Staines A, Tuffnell D. A randomized double-blind placebo controlled trial of fish oil in high risk pregnancy Br J Obstet Gynaecol 1995;102:95-100.
93. Walsh SW. Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985;152:335-40.
94. O'Brien PM, Pipkin FB. The effects of deprivation of prostaglandin precursors on vascular sensitivity to angiotensin II in the pregnancy rabbit. Br J Pharmacol 1979;65:29-34.
95. Patrignani P, Fabozzi P, Patrano C. Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects. J Clin Invest 1982;69:1366-72.
96. Beaufils M, Uzan S, Demsimoni R, Colau JC. Prevention of preeclampsia by early platelet therapy. Lancet 1985;1:840-2.
97. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Low-dose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive pamigravidae. Lancet 1986;1:1-3.
98. Imperiale TF, Parulis AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991;266:280-4.
99. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Racco L, et al and NIHCD. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnancy women. N Engl J Med 1993;329:1213-8.
100. Italian Study of Aspirin in Pregnancy. Low-dose aspirin in prevention and treatment of inuputerine growth retardation and pregnancy-induced hypertension. Lancet 1993;341:396-400.
101. Beilin L. Aspirin and preeclampsia [editorial]. BMJ 1994;308:1250.
102. Rey E, Derderian F. Effermit́ de l'aspirine a faible dose au cours de la grossesse en fonction des famous de risque matermis et foctaux. J Soc Obstet Gynecol Can 1996;18:1051-66.
103. Garrica PR. The collaborative low-dose Aspirin study in pregnancy. J Soc Obstet Gynecol Can 1991;13:51-7.
104. Sibai BM, Carlus SN, Thom E, Shaw R, McNellis D and the National Institute of Child Health and Human Development. Maternal-Fetal Medicine Network. Low-dose aspirin in nulliparous women: safety of continuous epidural block and correlations between bleeding time and maternal-neonatal bleeding complications. Am J Obstet Gynecol 1995;172:1553-7.
105. Richards SR, Nelson DM, Zuspan FP. Calcium levels in normal and hypertensive pregnant patients. Am J Obstet Gynecol 1984;149:168-71.